The Dizzying World of Post-COVID POTS: Symptoms, Potential Mechanisms and Therapies

Oren Cohen, MD, Head of Clinical Pharmacology Services and Chief Medical Officer, Labcorp Drug Development

Oren Cohen, MD, joined Labcorp Drug Development in December 2017 to serve as head of Clinical Pharmacology Services and Chief Medical Officer (CMO). Oren has extensive clinical development experience, most recently from Viamet Pharmaceuticals where he was CMO. He brings more than 30 years of healthcare experience to the role, including several senior medical and operational leadership positions at IQVIA, including Chief Medical and Scientific Officer and global head of Early Clinical Development.

Oren received his MD from Duke University and served his internship and residency at The New York Hospital, Cornell Medical Center in New York City. He completed his infectious diseases fellowship at the National Institute of Allergy and Infectious Diseases (NIAID) and stayed on to become an investigator in the Laboratory of Immunoregulation where he conducted basic and translational research on the immunopathogenesis of HIV infection under the supervision of Dr. Anthony Fauci. He served on the national antiretroviral guidelines panel and ultimately served as Assistant Director for Medical Affairs for NIAID.

Oren has published scientific papers in Science, The New England Journal of Medicine, The Lancet, The Journal of Clinical Investigation and Proceedings of the National Academy of Sciences, among others. He is a Fellow of the Infectious Diseases Society of America and a Consulting Professor of Medicine at Duke University Medical Center.

Artur Fedorowski, MD, PhD, Senior Consultant and Head of Syncope Unit, Dept. of Cardiology, Karolinska University Hospital

Dr. Artur Fedorowski earned his MD and PhD degrees from Wrocław Medical University, Poland, followed by specialist training in Sweden in general medicine, internal medicine and cardiology. He serves as a Senior Consultant and Head of Syncope Unit, Dept. of Cardiology at Karolinska University Hospital, and holds an academic position as an Associate Professor in the Department of Clinical Sciences at Lund University, both in Sweden. His research areas include syncope, orthostatic hypotension, cardiac arrhythmias, cardiovascular autonomic dysfunction, hypertension, biomarkers, autoimmune cardiovascular diseases and genetics of cardiovascular disease.

Dr. Fedorowski is a member of the Task Force Group of European Society of Cardiology for Syncope Guidelines and of the National Institutes of Health (U.S.) Expert Group on Postural Orthostatic Tachycardia Syndrome. He has authored more than 135 peer-reviewed publications and contributed to five books. He has also served as a guest editor for Frontiers in Cardiovascular Medicine and as a reviewer for more than 60 medical journals.

Brian Olshansky, MD, Professor Emeritus, University of Iowa; Adjunct Professor, Des Moines University; Clinical Cardiac Electrophysiologist

Brian Olshansky, MD, FACC, FAHA, FHRS, FESC, a board-certified, internationally known, clinical cardiac electrophysiologist graduated from Carleton College and University of Arizona School of Medicine, undertook his residency at Bellevue/NYU Hospitals and cardiology fellowship at the University of Iowa followed by electrophysiology training at the University of Alabama at Birmingham. He directed two cardiac electrophysiology programs – Loyola University Medical Center in Maywood, Illinois and the University of Iowa Hospitals and Clinics in Iowa City. He is Professor Emeritus at the University of Iowa, Adjunct Professor at Des Moines University and a cardiac electrophysiologist in practice in Iowa and Illinois.

Dr. Olshansky is known for his diversity of interests ranging from the technological and mechanistic aspects of cardiac electrophysiology to the holistic issues regarding medical care and the doctor-patient relationship. He has educated numerous cardiology and cardiac electrophysiology fellows, many of whom have gone onto brilliant careers.